FEBU

Fellow of the European Board of Urology

Prostate Cancer Risk StratificationEnglish
Exam overview

Practice session

A 69-year-old man has newly diagnosed prostate cancer with PSA 28 ng/mL, cT2c disease, and biopsy ISUP Grade Group 2. He has no symptoms of metastasis. Which statement about risk grouping and staging is most appropriate?

Loading your practice session…